Experience the difference with Axonics SNM Therapy

Learn about Sacral Neuromodulation (SNM) therapy for the treatment of Urinary and Faecal Incontinence

Experience the difference, experience Axonic SNM therapy

Living with urinary or faecal incontinence can affect your confidence, daily routines and quality of life.²² Axonics Sacral Neuromodulation (SNM) Therapy is designed to provide long-lasting relief for people living with bladder and bowel control conditions, helping you get back to the activities that matter most.

Axonics SNM Therapy combines proven sacral neuromodulation therapy with technology designed around patient comfort, convenience and choice.

Small, discreet implant design
Long-lasting therapy with up to 15–20+ years of battery life*
Choice of rechargeable or recharge-free²³ neurostimulators
Pocket-sized, easy-to-use patient remote
Ongoing patient education and support
Proven therapy for bladder and bowel control symptoms

Choose the Axonics SNM System that suits you

Everyone’s needs and lifestyle are different. Axonics SNM Therapy offers a choice of rechargeable or recharge-free neurostimulators, allowing you and your doctor to select the option that best suits your preferences without compromising therapy longevity.²⁸

Both options are designed to provide long-lasting²³ sacral neuromodulation therapy while offering different approaches to charging and device size.

Axonics F15 Recharge-Free Sacral Neuromodulation

The Axonics F15™ is designed for patients who prefer a recharge-free SNM system.

As the longest-lived, truly recharge-free device, the Axonics F15 offers up to 17.6 years of battery life at 1mA and more than 20 years at lower energy settings¹* in a 10cc device. No system components need to be recharged.

Axonics R20 Rechargeable Sacral Neuromodulation

The Axonics R20™ is a small, rechargeable neurostimulator designed for long-lasting²³ therapy with fewer charging interruptions.

Its open-ended battery life is designed to last 20+ years, with patients able to go approximately 6–10 months between charging sessions. The R20 has a compact 5cc device size.

How do I know if SNM Therapy is suitable for my symptoms?

Trialling the therapy, before proceeding with a long-term implant, your doctor may recommend a short trial of an Axonics therapy to evaluate its effectiveness in managing your symptoms.

Simple Control of Your Axonics SNM Therapy

Your Axonics SNM system includes a pocket-sized remote control that allows you to manage your therapy and make adjustments when needed.

The remote:

Is pocket-sized and easy to use
Requires no external antennas or communicators
Allows therapy level adjustments for both trial and permanent therapy
Allows an MRI technician to check system readiness before a full-body MRI

Doctor assisting patient in MRI scanner.

Can I have an MRI with an Axonics SNM implant?

The Axonics Sacral Neuromodulation systems are MRI Conditional, which means eligible patients can undergo MRI scans when the specified conditions and guidelines are followed.

If you need an MRI, tell your doctor and MRI provider that you have an Axonics SNM implant. Your healthcare team can confirm your device type and ensure the appropriate MRI conditions are met before your scan.

Knowing that your Axonics SNM system is MRI Conditional can provide reassurance if diagnostic imaging is needed in the future. If you have questions about your implant or an upcoming MRI scan, speak with your healthcare provider for guidance specific to your device and circumstances.

References:

* Default stimulation settings for Axonics are shown at Frequency 14 Hz, Pulse Width 210 μs.

** Depending on therapy settings

Company data on file. 110-0022-002rA
ARTISTRY Registry data on file. October 2023
Company data on file 105-0124-001

3. Company data on file 105-0139. Impedance measured across devices sold, which includes devices sold but not yet implanted. Impedance rate on devices actually implanted may be higher.

4. Pezzella A, McCrery R, Lane F, et al. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system. Neurourol Urodyn. 2021

22. Pezzella A, McCrery R, Lane F, et al. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system. Neurourol Urodyn. 2021;40(2):714-721. doi:10.1002/nau.24615

23. Company data on file. 110-0022-002rA

Disclaimer and endnotes:

Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.

Individual symptoms, situations, circumstances and results may vary. This quiz is meant for information purposes only, it is not intended to be used for medical diagnosis or treatment or as a substitute for professional medical advice. Please consult your doctor or qualified healthcare provider regarding your condition and appropriate medical treatment. This site is intended for Australian residents only. Please review the Boston Scientific Privacy Policy, for practices on the collection, storage, use and disclosure of your personal information.

Content of videos are for Information Purposes only and does not constitute medical advice. BSC strongly recommends that you consult with your physician on all matters pertaining to your health or to address any questions.

The Axonics SNM system is not a first-line treatment. Surgery is required for use of Axonics SNM system, and any surgical procedure carries risk. Outcomes vary for each patient. Patients should consult their healthcare professional about factors that could impact response.

CAUTION: This product is not available for purchase by the general public. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com.

Australia and New Zealand: Boston Scientific Pty Ltd | PO Box 332 Botany NSW 1455 Australia